+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pulmonary/ Respiratory Drug Delivery - Market Analysis, Trends, and Forecasts

  • ID: 4805424
  • Report
  • 142 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • 3M Company
  • Astrazeneca Plc
  • Cipla
  • Glaxosmithkline Plc
  • Merck & Co.
  • Novartis Ag
  • MORE
Pulmonary/ Respiratory Drug Delivery market worldwide is projected to grow by US$20.6 Billion, driven by a compounded growth of 6.1%. Metered dose, one of the segments analyzed and sized in this study, displays the potential to grow at over 6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$42 Billion by the year 2025, Metered dose will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$964.3 Million to the region's size and clout in the next 5 to 6 years. Over US$959.8 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Metered dose will reach a market size of US$3.2 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6% over the next couple of years and add approximately US$3.6 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • 3M Company
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Cipla Ltd.
  • GlaxoSmithKline PLC
  • Merck & Co., Inc.
  • Novartis AG
  • Omron Corporation
  • Sunovion Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 3M Company
  • Astrazeneca Plc
  • Cipla
  • Glaxosmithkline Plc
  • Merck & Co.
  • Novartis Ag
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Pulmonary/ Respiratory Drug Delivery Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Pulmonary/ Respiratory Drug Delivery Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Pulmonary/ Respiratory Drug Delivery Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Pulmonary/ Respiratory Drug Delivery Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Metered dose (Device Type) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Metered dose (Device Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Metered dose (Device Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Dry Powder (Device Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Dry Powder (Device Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Dry Powder (Device Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Nebulizer (Device Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Nebulizer (Device Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Nebulizer (Device Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Accessories (Device Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 14: Accessories (Device Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 15: Accessories (Device Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Chronic Obstructive Pulmonary Disease (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 17: Chronic Obstructive Pulmonary Disease (Application) Global Historic Analysis in US$ Million by Region/Country: 2009-2017

TABLE 18: Chronic Obstructive Pulmonary Disease (Application) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 19: Asthma (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025

TABLE 20: Asthma (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017

TABLE 21: Asthma (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025

TABLE 22: Cystic Fibrosis (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025

TABLE 23: Cystic Fibrosis (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017

TABLE 24: Cystic Fibrosis (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 25: Other Applications (Application) Worldwide Sales in US$ Million by Region/Country: 2018-2025

TABLE 26: Other Applications (Application) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017

TABLE 27: Other Applications (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Pulmonary/ Respiratory Drug Delivery Market Share (in %) by Company: 2019 & 2025

TABLE 28: United States Pulmonary/ Respiratory Drug Delivery Market Estimates and Projections in US$ Million by Device Type: 2018 to 2025

TABLE 29: Pulmonary/ Respiratory Drug Delivery Market in the United States by Device Type: A Historic Review in US$ Million for 2009-2017

TABLE 30: United States Pulmonary/ Respiratory Drug Delivery Market Share Breakdown by Device Type: 2009 VS 2019 VS 2025

TABLE 31: United States Pulmonary/ Respiratory Drug Delivery Latent Demand Forecasts in US$ Million by Application: 2018 to 2025

TABLE 32: Pulmonary/ Respiratory Drug Delivery Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017

TABLE 33: Pulmonary/ Respiratory Drug Delivery Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025

CANADA

TABLE 34: Canadian Pulmonary/ Respiratory Drug Delivery Market Estimates and Forecasts in US$ Million by Device Type: 2018 to 2025

TABLE 35: Canadian Pulmonary/ Respiratory Drug Delivery Historic Market Review by Device Type in US$ Million: 2009-2017

TABLE 36: Pulmonary/ Respiratory Drug Delivery Market in Canada: Percentage Share Breakdown of Sales by Device Type for 2009, 2019, and 2025

TABLE 37: Canadian Pulmonary/ Respiratory Drug Delivery Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025

TABLE 38: Pulmonary/ Respiratory Drug Delivery Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017

TABLE 39: Canadian Pulmonary/ Respiratory Drug Delivery Market Share Analysis by Application: 2009 VS 2019 VS 2025

JAPAN

TABLE 40: Japanese Market for Pulmonary/ Respiratory Drug Delivery: Annual Sales Estimates and Projections in US$ Million by Device Type for the Period 2018-2025

TABLE 41: Pulmonary/ Respiratory Drug Delivery Market in Japan: Historic Sales Analysis in US$ Million by Device Type for the Period 2009-2017

TABLE 42: Japanese Pulmonary/ Respiratory Drug Delivery Market Share Analysis by Device Type: 2009 VS 2019 VS 2025

TABLE 43: Japanese Demand Estimates and Forecasts for Pulmonary/ Respiratory Drug Delivery in US$ Million by Application: 2018 to 2025

TABLE 44: Japanese Pulmonary/ Respiratory Drug Delivery Market in US$ Million by Application: 2009-2017

TABLE 45: Pulmonary/ Respiratory Drug Delivery Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025

CHINA

TABLE 46: Chinese Pulmonary/ Respiratory Drug Delivery Market Growth Prospects in US$ Million by Device Type for the Period 2018-2025

TABLE 47: Pulmonary/ Respiratory Drug Delivery Historic Market Analysis in China in US$ Million by Device Type: 2009-2017

TABLE 48: Chinese Pulmonary/ Respiratory Drug Delivery Market by Device Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 49: Chinese Demand for Pulmonary/ Respiratory Drug Delivery in US$ Million by Application: 2018 to 2025

TABLE 50: Pulmonary/ Respiratory Drug Delivery Market Review in China in US$ Million by Application: 2009-2017

TABLE 51: Chinese Pulmonary/ Respiratory Drug Delivery Market Share Breakdown by Application: 2009 VS 2019 VS 2025

EUROPE

Market Facts & Figures

European Pulmonary/ Respiratory Drug Delivery Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 52: European Pulmonary/ Respiratory Drug Delivery Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 53: Pulmonary/ Respiratory Drug Delivery Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 54: European Pulmonary/ Respiratory Drug Delivery Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 55: European Pulmonary/ Respiratory Drug Delivery Market Estimates and Forecasts in US$ Million by Device Type: 2018-2025

TABLE 56: Pulmonary/ Respiratory Drug Delivery Market in Europe in US$ Million by Device Type: A Historic Review for the Period 2009-2017

TABLE 57: European Pulmonary/ Respiratory Drug Delivery Market Share Breakdown by Device Type: 2009 VS 2019 VS 2025

TABLE 58: European Pulmonary/ Respiratory Drug Delivery Addressable Market Opportunity in US$ Million by Application: 2018-2025

TABLE 59: Pulmonary/ Respiratory Drug Delivery Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017

TABLE 60: European Pulmonary/ Respiratory Drug Delivery Market Share Analysis by Application: 2009 VS 2019 VS 2025

FRANCE

TABLE 61: Pulmonary/ Respiratory Drug Delivery Market in France by Device Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 62: French Pulmonary/ Respiratory Drug Delivery Historic Market Scenario in US$ Million by Device Type: 2009-2017

TABLE 63: French Pulmonary/ Respiratory Drug Delivery Market Share Analysis by Device Type: 2009 VS 2019 VS 2025

TABLE 64: Pulmonary/ Respiratory Drug Delivery Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025

TABLE 65: French Pulmonary/ Respiratory Drug Delivery Historic Market Review in US$ Million by Application: 2009-2017

TABLE 66: French Pulmonary/ Respiratory Drug Delivery Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025

GERMANY

TABLE 67: Pulmonary/ Respiratory Drug Delivery Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Device Type for the Period 2018-2025

TABLE 68: German Pulmonary/ Respiratory Drug Delivery Historic Market Analysis in US$ Million by Device Type: 2009-2017

TABLE 69: German Pulmonary/ Respiratory Drug Delivery Market Share Breakdown by Device Type: 2009 VS 2019 VS 2025

TABLE 70: Pulmonary/ Respiratory Drug Delivery Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025

TABLE 71: German Pulmonary/ Respiratory Drug Delivery Market in Retrospect in US$ Million by Application: 2009-2017

TABLE 72: Pulmonary/ Respiratory Drug Delivery Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025

ITALY

TABLE 73: Italian Pulmonary/ Respiratory Drug Delivery Market Growth Prospects in US$ Million by Device Type for the Period 2018-2025

TABLE 74: Pulmonary/ Respiratory Drug Delivery Historic Market Analysis in Italy in US$ Million by Device Type: 2009-2017

TABLE 75: Italian Pulmonary/ Respiratory Drug Delivery Market by Device Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 76: Italian Demand for Pulmonary/ Respiratory Drug Delivery in US$ Million by Application: 2018 to 2025

TABLE 77: Pulmonary/ Respiratory Drug Delivery Market Review in Italy in US$ Million by Application: 2009-2017

TABLE 78: Italian Pulmonary/ Respiratory Drug Delivery Market Share Breakdown by Application: 2009 VS 2019 VS 2025

UNITED KINGDOM

TABLE 79: United Kingdom Market for Pulmonary/ Respiratory Drug Delivery: Annual Sales Estimates and Projections in US$ Million by Device Type for the Period 2018-2025

TABLE 80: Pulmonary/ Respiratory Drug Delivery Market in the United Kingdom: Historic Sales Analysis in US$ Million by Device Type for the Period 2009-2017

TABLE 81: United Kingdom Pulmonary/ Respiratory Drug Delivery Market Share Analysis by Device Type: 2009 VS 2019 VS 2025

TABLE 82: United Kingdom Demand Estimates and Forecasts for Pulmonary/ Respiratory Drug Delivery in US$ Million by Application: 2018 to 2025

TABLE 83: United Kingdom Pulmonary/ Respiratory Drug Delivery Market in US$ Million by Application: 2009-2017

TABLE 84: Pulmonary/ Respiratory Drug Delivery Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 85: Rest of Europe Pulmonary/ Respiratory Drug Delivery Market Estimates and Forecasts in US$ Million by Device Type: 2018-2025

TABLE 86: Pulmonary/ Respiratory Drug Delivery Market in Rest of Europe in US$ Million by Device Type: A Historic Review for the Period 2009-2017

TABLE 87: Rest of Europe Pulmonary/ Respiratory Drug Delivery Market Share Breakdown by Device Type: 2009 VS 2019 VS 2025

TABLE 88: Rest of Europe Pulmonary/ Respiratory Drug Delivery Addressable Market Opportunity in US$ Million by Application: 2018-2025

TABLE 89: Pulmonary/ Respiratory Drug Delivery Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017

TABLE 90: Rest of Europe Pulmonary/ Respiratory Drug Delivery Market Share Analysis by Application: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 91: Pulmonary/ Respiratory Drug Delivery Market in Asia-Pacific by Device Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 92: Asia-Pacific Pulmonary/ Respiratory Drug Delivery Historic Market Scenario in US$ Million by Device Type: 2009-2017

TABLE 93: Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Share Analysis by Device Type: 2009 VS 2019 VS 2025

TABLE 94: Pulmonary/ Respiratory Drug Delivery Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025

TABLE 95: Asia-Pacific Pulmonary/ Respiratory Drug Delivery Historic Market Review in US$ Million by Application: 2009-2017

TABLE 96: Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025

REST OF WORLD

TABLE 97: Rest of World Pulmonary/ Respiratory Drug Delivery Market Estimates and Forecasts in US$ Million by Device Type: 2018 to 2025

TABLE 98: Rest of World Pulmonary/ Respiratory Drug Delivery Historic Market Review by Device Type in US$ Million: 2009-2017

TABLE 99: Pulmonary/ Respiratory Drug Delivery Market in Rest of World: Percentage Share Breakdown of Sales by Device Type for 2009, 2019, and 2025

TABLE 100: Rest of World Pulmonary/ Respiratory Drug Delivery Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025

TABLE 101: Pulmonary/ Respiratory Drug Delivery Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017

TABLE 102: Rest of World Pulmonary/ Respiratory Drug Delivery Market Share Analysis by Application: 2009 VS 2019 VS 2025

IV. COMPETITION

3M COMPANY

ASTRAZENECA PLC

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

CIPLA

GLAXOSMITHKLINE PLC

MERCK & CO.

NOVARTIS AG

OMRON CORPORATION

SUNOVION PHARMACEUTICALS

TEVA PHARMACEUTICAL INDUSTRIES

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • 3M Company
  • Astrazeneca Plc
  • Boehringer Ingelheim International Gmbh
  • Cipla
  • Glaxosmithkline Plc
  • Merck & Co.
  • Novartis Ag
  • Omron Corporation
  • Sunovion Pharmaceuticals
  • Teva Pharmaceutical Industries
Note: Product cover images may vary from those shown
Adroll
adroll